What should a 39-year-old female with type 2 diabetes (T2D) be told regarding her blood work results showing leukocytosis, a hemoglobin A1c (HbA1c) level of 7.6, and microalbuminuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

You should aim to achieve an HbA1c level between 7% and 8%, as your current A1C of 7.6% is slightly above the target, indicating your average blood glucose has been around 170 mg/dL over the past three months 1. Your white blood cell count is slightly elevated at 10.78, which could indicate a mild infection or inflammation, but your kidney function appears good with a normal microalbumin level of 8.7, suggesting you haven't developed diabetic kidney disease yet, though we should continue monitoring this annually along with other diabetes complications like eye and foot problems. It's essential to personalize your glycemic control goals based on your individual characteristics, such as your general health, life expectancy, and treatment burden, and to consider the potential benefits and harms of more intensive glycemic control 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Laboratory Results for 39-year-old Female with Type 2 Diabetes

  • The patient's laboratory results show a WBC count of 10.78, which is slightly elevated, but all other labs are normal.
  • The A1C level is 7.6, indicating that the patient's blood sugar levels are not optimally controlled, as the American Diabetes Association recommends an A1C level below 7% for most adults with type 2 diabetes 2, 3, 4.
  • The microalbumin level is 8.7, which is a measure of kidney function and may indicate early signs of kidney damage, a common complication of diabetes 2, 4.

Implications of Laboratory Results

  • The patient's A1C level suggests that her current treatment regimen may need to be adjusted to achieve better blood sugar control, and medications such as sitagliptin or metformin may be considered 2, 3, 4.
  • The patient's microalbumin level should be monitored closely, and measures should be taken to slow the progression of kidney disease, such as controlling blood pressure and blood sugar levels 2, 4.

Related Questions

What is the expected A1c (glycated hemoglobin) reduction with Janumet (sitagliptin and metformin) in patients with type 2 diabetes?
Should I discontinue Rybelsus (semaglutide) with a normal Hemoglobin A1C level?
What are the calculated prandial and basal insulin doses for a patient with a weight of 77 kilograms and a Hemoglobin A1c (HbA1c) level of 13.2%?
Can a healthcare provider prescribe sitagliptin (DPP-4 inhibitor) + metformin (biguanide) with glicazide (sulfonylurea) at the same time?
What additional interventions can be implemented to reduce the hemoglobin A1c (HbA1c) level in a 71-year-old female patient with type 2 diabetes mellitus (T2DM), currently taking Jardiance (Empagliflozin) 25mg and Metformin 500mg, with a persistent elevated HbA1c level of 8.1%?
Can black coffee be consumed before fasting laboratory tests?
What is the treatment for a patient with atrial fibrillation in critical care?
What is the diagnosis for a 31-year-old female who experienced a traumatic injury from falling down 5 stairs, landing on her foot, with subsequent significant bruising, limited range of motion (ROM), and recent onset of numbness and tingling in her toes and heel, as well as warmth and redness in her left lateral calf, one week post-injury?
Can heterogeneity of the myometrium, a 13mm endometrium, subcentimeter uterine fibroids (leiomyomas), and a 2.5cm left ovarian follicular cyst be indicative of adenomyosis?
What questions should be asked to assess a person's mental capacity?
What is the treatment for a patient with atrial fibrillation in critical care?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.